David Montez
2014
In 2014, David Montez earned a total compensation of $668.7K as Former Controller and Chief Accounting Officer at PDL BioPharma, a 222% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $299,933 |
---|---|
Salary | $249,600 |
Stock Awards | $91,140 |
Other | $28,000 |
Total | $668,673 |
Montez received $299.9K in non-equity incentive plan, accounting for 45% of the total pay in 2014.
Montez also received $249.6K in salary, $91.1K in stock awards and $28K in other compensation.
Rankings
In 2014, David Montez's compensation ranked 9,244th out of 13,032 executives tracked by ExecPay. In other words, Montez earned more than 29.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,244 out of 13,032 | 29th |
Division Manufacturing | 3,474 out of 4,966 | 30th |
Major group Chemicals And Allied Products | 1,173 out of 1,686 | 30th |
Industry group Drugs | 931 out of 1,365 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 170 out of 236 | 28th |
Source: SEC filing on April 20, 2016.
Montez's colleagues
We found four more compensation records of executives who worked with David Montez at PDL BioPharma in 2014.